SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to speculation of a potential short squeeze, with community members actively discussing strategies to push the stock higher and liquidate shorts. The stock's high volatility and recent price action are fueling the conversation, as traders compare it to other low-float stocks that have experienced significant surges. Some are noting the company's small market cap and low float, which could contribute to rapid price movements.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its RAD 101 Phase 2b imaging trial, sparking significant community discussion around the potential for a short squeeze and high price targets. The stock's impressive pre-market surge and subsequent volatility have traders weighing the potential for further gains against the risk of a pullback. A forthcoming webinar is adding to the anticipation, with many speculating on its impact on the stock's direction.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, driven by sector-wide concerns about an AI bubble and delayed data center projects, despite a major Microsoft deal. Community sentiment is divided, with some calling the stock a "scam" and expecting further declines, while others view the dip as a buying opportunity, citing strong fundamentals and long-term growth potential. Discussions also revolve around potential market manipulation and the stock's correlation with Bitcoin's price movements.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to other HK stocks that have seen explosive runs. Community members are highlighting the company's recent acquisitions and revenue, anticipating news that could catalyze a significant price movement. Some traders caution against FOMO due to the stock's volatility and low volume.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors anticipate data and potential catalysts related to its immunology pipeline. Community discussions revolve around upcoming conference calls, data releases, and speculation about a potential buyout, particularly concerning the ongoing litigation with Eli Lilly. Traders are also actively monitoring technical indicators and analyst price targets, contributing to the increased attention surrounding NKTR.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's stock is trending amid discussions around its AI strategy and potential partnerships, particularly after some analysts suggested it's lagging behind competitors. The community is debating whether Apple's lower AI spending is a strength or weakness, with some viewing it as a safe haven play. Additionally, there's speculation about Apple's next moves in response to increasing competition and evolving market dynamics.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

OMER is trending as investors anticipate a potential FDA approval for Narsoplimab by late December, with the community actively discussing the likelihood of approval and potential buyout scenarios. Recent price action and large put buys have sparked speculation about a possible news leak or market manipulation. Bullish investors express confidence in the drug's efficacy and Novo Nordisk's backing, viewing any price dips as buying opportunities.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending downwards as the community discusses a recent significant single-day drop, with some attributing it to broader market sentiment and correlation with Bitcoin's performance. Despite this, some investors are taking the opportunity to buy the dip, citing the company's existing contracts and long-term potential in AI infrastructure. Discussions also revolve around potential hyperscaler deals and their impact on the stock's future.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid speculation around a potential buyout or partnership, with the community closely watching for further developments. Some are encouraged by the pipeline and renewed biotech sector interest, while others express concern over the company's direction and cash flow. Discussions also include the potential impact of regulatory changes and opinions on vaccine safety.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around upcoming staking opportunities and the coin's narrative challenging traditional retirement systems. The community emphasizes its strong holder base and sees the project as a movement against financial norms. Talk centers on the potential for significant gains and the relatability of the anti-establishment message.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving Average - Here's What Happened

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Above Fifty Day Moving Average - What's Next...

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving Average - Here's What Happened

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below Fifty Day Moving Average - Here's Why...

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving Average - Should You Sell?

Seres Therapeutics (NASDAQ:MCRB) Share Price Passes Below 50-Day Moving Average - Time to Sell...

Insider Selling: Seres Therapeutics (NASDAQ:MCRB) Insider Sells 1,257 Shares of Stock

Seres Therapeutics, Inc. (NASDAQ:MCRB - Get Free Report) insider Matthew Henn sold 1,257 shares of the business's stock in a transaction on Saturday, November 15th. The stock was sold at an average...

Seres Therapeutics (NASDAQ:MCRB) Share Price Crosses Below Fifty Day Moving Average - Time to Sell?

Seres Therapeutics (NASDAQ:MCRB) Share Price Crosses Below 50 Day Moving Average - Here's What Happened...

All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy

Seres Therapeutics (MCRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Seres Therapeutics (MCRB)'s Technical Outlook is Bright After Key Golden Cross

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Current Price	$15.90
Prev Close	$16.94
Open	$17.02
Dividend Yield	0.00%
50-Day Moving Average	$17.86
Beta	0.95
Avg. Volume	341,908.37
PE Ratio	27.90

52-Week High	$29.98
52-Week Low	$6.53
Market Capitalization	$153.25M
EPS (Annual)	-$18.86
Price to Book	3.40
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MCRB
Seres Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MCRB News

MCRBSeres Therapeutics Inc